Literature DB >> 9003072

Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor.

F Lanau1, M T Zenner, O Civelli, D S Hartman.   

Abstract

The catecholamines dopamine (DA), epinephrine (EP), and norepinephrine (NE) play important roles in learning and memory, emotional states, and control of voluntary movement, as well as cardiovascular and kidney function. They activate distinct but overlapping neuronal pathways through five distinct DA receptors (D1R-D5R) and at least 10 different adrenergic receptors (alpha 1a/b/c, alpha 2a/b/c-1/c-2, and beta 1/beta 2/beta 3). The D4R, which is localized to mesolimbic areas of the brain implicated in affective and emotional behavior, has a deduced amino acid sequence with homology to both adrenergic and dopaminergic receptor subtypes. We report here that DA, EP, and NE all show binding in the nanomolar range to three isoforms of the recombinant human D4R (hD4R): D4.2, D4.4, and D4.7. Submicromolar concentrations of DA, EP, and NE were sufficient to activate hD4R isoforms in two different functional assays: agonist-induced guanosine 5'-O-(3-[35S]thiotriphosphate) binding and modulation of adenylyl cyclase activity. DA was approximately fivefold more potent than EP and NE at the D4R, whereas activation of the human D2R required at least 100-fold higher catecholamine concentrations. Functional activation of the D4R by multiple neurotransmitters may provide a novel mechanism for integration of catecholamine signaling in the brain and periphery.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003072     DOI: 10.1046/j.1471-4159.1997.68020804.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  31 in total

Review 1.  Non-stimulant treatments for ADHD.

Authors:  J Biederman; T Spencer
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  The dopamine D4 receptor: biochemical and signalling properties.

Authors:  Pieter Rondou; Guy Haegeman; Kathleen Van Craenenbroeck
Journal:  Cell Mol Life Sci       Date:  2010-02-18       Impact factor: 9.261

3.  Psychotherapy for the patient with adult ADHD.

Authors:  Julie P Gentile; Rafay Atiq
Journal:  Psychiatry (Edgmont)       Date:  2006-08

4.  Adult ADHD: Diagnosis, Differential Diagnosis, and Medication Management.

Authors:  Julie P Gentile; Rafay Atiq; Paulette M Gillig
Journal:  Psychiatry (Edgmont)       Date:  2006-08

5.  Structural insights into the human D1 and D2 dopamine receptor signaling complexes.

Authors:  Youwen Zhuang; Peiyu Xu; Chunyou Mao; Lei Wang; Brian Krumm; X Edward Zhou; Sijie Huang; Heng Liu; Xi Cheng; Xi-Ping Huang; Dan-Dan Shen; Tinghai Xu; Yong-Feng Liu; Yue Wang; Jia Guo; Yi Jiang; Hualiang Jiang; Karsten Melcher; Bryan L Roth; Yan Zhang; Cheng Zhang; H Eric Xu
Journal:  Cell       Date:  2021-02-10       Impact factor: 41.582

6.  Transmembrane segment five serines of the D4 dopamine receptor uniquely influence the interactions of dopamine, norepinephrine, and Ro10-4548.

Authors:  David F Cummings; Spencer S Ericksen; Angela Goetz; John A Schetz
Journal:  J Pharmacol Exp Ther       Date:  2010-03-09       Impact factor: 4.030

Review 7.  Pharmacological models of ADHD.

Authors:  R M Kostrzewa; J P Kostrzewa; R A Kostrzewa; P Nowak; R Brus
Journal:  J Neural Transm (Vienna)       Date:  2007-11-12       Impact factor: 3.575

8.  Dopamine binds to alpha(2)-adrenergic receptors in the song control system of zebra finches (Taeniopygia guttata).

Authors:  Charlotte A Cornil; Christina B Castelino; Gregory F Ball
Journal:  J Chem Neuroanat       Date:  2007-11-04       Impact factor: 3.052

9.  Conditioned place preference and locomotor activity in response to methylphenidate, amphetamine and cocaine in mice lacking dopamine D4 receptors.

Authors:  P K Thanos; C Bermeo; M Rubinstein; K L Suchland; G J Wang; D K Grandy; N D Volkow
Journal:  J Psychopharmacol       Date:  2009-03-12       Impact factor: 4.153

Review 10.  Orphan GPCRs and neuromodulation.

Authors:  Olivier Civelli
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.